Study guide

11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules

Key Takeaways Explain This Topic AI

Class 00 means diagnosed at the facility and all treatment, or the decision not to treat, happened elsewhere; code it only when it is known that the patient went elsewhere, otherwise use 10.

If a patient diagnosed at the facility refuses recommended treatment or a decision is made not to treat, the Class of Case is 14, not 00; if there is no information about whether or where the patient was treated, it is 10.

Classes 11 and 12 cover diagnosis in the office of a staff physician (employed, under contract, or with routine admitting privileges) with part (11) or all (12) of first-course treatment at the facility.

Classes 13 and 14 cover diagnosis at the facility with part (13) or all (14) of first-course treatment at the facility; 20, 21 and 22 cover diagnosis elsewhere with treatment at the facility NOS, part, or all.

Class of Case can change during the first course of care; continuation of first-course maintenance therapy at the facility (not in-transit) can make a case diagnosed and started elsewhere Class 21.

Last updated: September 2026

Two questions decide the code

Where was the initial diagnosis made?

At the reporting facility (including services covered by its FEIN).

In the office of a staff physician , meaning one who is employed by the facility, under contract with it, or has routine admitting privileges there.

Elsewhere , meaning another hospital or a non-staff physician.

How much first-course treatment, or decision not to treat, occurred at the facility?

None, part, all, or not specified (NOS).

The analytic codes (STORE 2025, item 610)

  • Code Diagnosis First-course treatment at the reporting facility
  • 00 At the reporting facility None : all treatment, or the decision not to treat, was done elsewhere
  • 10 At the facility or in a staff physician's office Part or all, or a decision not to treat, NOS
  • 11 In a staff physician's office Part at the facility
  • 12 In a staff physician's office All , or the decision not to treat, at the facility
  • 13 At the reporting facility Part at the facility, part elsewhere
  • 14 At the reporting facility All , or the decision not to treat, at the facility
  • 20 Elsewhere All or part at the facility, NOS
  • 21 Elsewhere Part at the facility, part elsewhere
  • 22 Elsewhere All , or the decision not to treat, at the facility

Mnemonic for the second digit: 1 = part, 2 = all in the 11/12 and 21/22 pairs; in the 13/14 pair, 3 = part, 4 = all . Codes ending in 0 (10, 20) are "NOS."

  • Rules that change the answer
  • 00 versus 10 versus 14

00 requires knowing the patient went elsewhere. STORE instructs registrars to document the referral (for example, NPI–Institution Referred To [2425] or the treating physician's NPI) to establish this.

If it is not known whether or where the patient was treated, code 10 . STORE's example is a homeless patient whose biopsy was positive at the hospital, with no information about later care.

If the patient refuses recommended treatment, or the physicians decide not to treat (for example, active surveillance, or the patient is too ill), and that decision was made at the facility, code 14 . Class 00 is used for "decision not to treat" only when that decision was made elsewhere .

Class 00 is analytic: it is abstracted and submitted to the NCDB, but CoC does not require Class 00 cases to be staged or followed .

Staff physician offices

A biopsy done in a staff physician's own office counts as a diagnosis in a staff physician's office (11 or 12), not at the facility.

Treatment given in a staff physician's office is treatment " elsewhere ," because the office is not within the hospital's responsibility.

If the hospital buys a physician practice , determine whether the practice is now legally part of the hospital. If it is not, treat its physicians like any other physician, with or without admitting privileges.

A biopsy by a staff physician off site, with a specimen the facility never reads, is not required to be abstracted unless the patient then receives first-course care at the facility. In that case the class is 11 or 12. If the diagnosing physician is not a staff physician, it is 20 or 21.

Treatment started elsewhere, continued here

In-transit care (temporary care while the patient is away from the usual practitioner) is nonanalytic Class 31 . Monitoring an oral medication started elsewhere is also Class 31.

If first-course radiation or chemotherapy infusion begins elsewhere and continues at the reporting facility and the care is not in-transit, the case is Class 21 .

Maintenance therapy that is part of the first-course plan (for example, continuing hormone therapy prescribed elsewhere), documented as prescribed or administered by your facility, makes the case Class 21 , even if active disease is gone.

Class of Case can change

STORE: "If information for coding Class of Case changes during the patient's first course of care, change the code accordingly." Examples:

A 00 patient returns for part of the planned treatment, so the case becomes 13 . Date of First Contact does not change.

A consult-only 30 patient returns for treatment, so the case becomes 20, 21 or 22 , and Date of First Contact moves to the date the case became analytic.

STORE examples, decoded

Scenario Code Why

Leukemia diagnosed at the facility; all care in the office of a physician with practice privileges 00 Diagnosis at the facility; care in a staff physician's office is "elsewhere"

Breast cancer diagnosed and operated on at the hospital; radiation at a hospital across the street under an agreement 13 Diagnosis at the facility; part of treatment elsewhere

Cancer found in a biopsy at the hospital; unable to learn whether the homeless patient got treatment 10 Diagnosis at the facility; treatment location unknown

Diagnosed by a staff physician; neoadjuvant radiation at another facility; resection at the reporting facility 11 Staff physician diagnosis; part of treatment at the facility

More worked scenarios

Melanoma: a punch biopsy in a staff dermatologist's office is read by the hospital's pathology department, and the patient has a wide re-excision at the hospital, which is all first-course treatment. The code is 12 , and Date of First Contact is the re-excision date. STORE's Date of First Contact example uses exactly this setup.

Prostate: a biopsy at the hospital, and the patient chooses active surveillance with the hospital's urologist. A decision not to treat at the facility gives 14 .

Lung: diagnosed by EBUS at another hospital, chemoradiation entirely at the reporting facility, so 22 .

Colon: diagnosed at the facility, and the patient travels to a cancer center for all treatment, documented with the referral NPI. The code is 00 , and the case is not staged or followed under CoC rules.

Loading diagram... Assigning an analytic Class of Case